Introduction Vonoprazan is a novel potassium-competitive acid blocker (P-CAB), introduced as a more potent and faster-acting alternative to proton pump inhibitors (PPIs). It is primarily used for acid-related disorders such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and Helicobacter pylori eradication. Mechanism of Action (Stepwise Points) Pharmacokinetics Clinical Uses Adverse Effects Comparative Analysis Feature … Read more
Introduction Strattera, the brand name for atomoxetine, is a non-stimulant medication used primarily in the treatment of attention-deficit hyperactivity disorder (ADHD). Unlike stimulant medications such as methylphenidate or amphetamines, atomoxetine works through selective modulation of norepinephrine. Mechanism of Action (Stepwise Points) Pharmacokinetics Clinical Uses Adverse Effects Comparative Analysis Feature Atomoxetine (Strattera) Methylphenidate Amphetamine Drug Class … Read more
Introduction Buprenorphine is a semi-synthetic opioid derived from thebaine, widely used in both pain management and opioid dependence treatment. Its unique receptor profile—acting as a partial agonist at μ-opioid receptors—gives it a favorable safety and efficacy profile compared to full agonists. Mechanism of Action (Stepwise Points) Pharmacokinetics Clinical Uses Adverse Effects Comparative Analysis Feature Buprenorphine … Read more
Introduction Alendronate is a nitrogen-containing bisphosphonate used primarily in the treatment and prevention of osteoporosis and other bone-resorptive disorders. It acts by inhibiting osteoclast-mediated bone resorption, thereby maintaining or increasing bone mineral density. Mechanism of Action (Stepwise Points) Pharmacokinetics Clinical Uses Adverse Effects Comparative Analysis Parameter Alendronate Risedronate Zoledronate Route Oral Oral IV Dosing Frequency … Read more
Introduction Levetiracetam is a widely used antiepileptic drug (AED) known for its unique mechanism of action, high tolerability, and minimal drug interactions. It is indicated in the treatment of various seizure types and is favored in both pediatric and adult populations. Mechanism of Action (Stepwise Points) Pharmacokinetics Clinical Uses Adverse Effects Comparative Analysis Feature Levetiracetam … Read more
Introduction Tetrabenazine is a centrally acting vesicular monoamine transporter 2 (VMAT2) inhibitor used primarily to manage hyperkinetic movement disorders. It is especially effective in reducing chorea associated with Huntington’s disease. By depleting monoamines such as dopamine from nerve terminals, it helps in restoring neurochemical balance in the basal ganglia. Mechanism of Action (Stepwise Points) Pharmacokinetics … Read more
Introduction Alteplase is a recombinant tissue plasminogen activator (rt-PA) used as a thrombolytic agent. It plays a crucial role in the dissolution of fibrin clots and is utilized primarily in acute ischemic stroke, myocardial infarction, and pulmonary embolism. This agent mimics the naturally occurring enzyme tissue plasminogen activator (tPA), facilitating clot breakdown and restoring blood … Read more
Introduction Apixaban is a direct oral anticoagulant (DOAC) used to prevent and treat thrombosis. It is specifically indicated for stroke prevention in non-valvular atrial fibrillation, treatment and prevention of venous thromboembolism (VTE), and management of deep vein thrombosis (DVT) and pulmonary embolism (PE). Its predictable pharmacokinetics and oral administration make it a widely used alternative … Read more
